Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(14%)
Results Posted
67%(2 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_1
1
14%
Ph phase_4
3
43%
Ph phase_2
3
43%

Phase Distribution

1

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
3(42.9%)
Phase 4Post-market surveillance
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
Recruiting1
unknown1
Terminated1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (14.3%)
Phase 23 (42.9%)
Phase 43 (42.9%)

Trials by Status

recruiting114%
unknown114%
terminated114%
enrolling_by_invitation114%
completed343%

Recent Activity

1 active trials
Showing 5 of 7
recruitingphase_2

A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)

NCT06873815
enrolling_by_invitationphase_2

Identification of Nerves Using Fluorescein Sodium

NCT06054178
completedphase_4

Dose Optimization for Safe and Efficient Fluorescein Angiography (DOSE Study)

NCT05664555
completedphase_2

Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560

NCT04351373
completedphase_1

The Study of Oral Fluorescite to Confirm the Authenticity of Point of Care Urine Samples

NCT04071080
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06873815Phase 2

A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)

Recruiting
NCT06054178Phase 2

Identification of Nerves Using Fluorescein Sodium

Enrolling By Invitation
NCT05664555Phase 4

Dose Optimization for Safe and Efficient Fluorescein Angiography (DOSE Study)

Completed
NCT04351373Phase 2

Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560

Completed
NCT04071080Phase 1

The Study of Oral Fluorescite to Confirm the Authenticity of Point of Care Urine Samples

Completed
NCT02478346Phase 4

Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions

Unknown
NCT02028325Phase 4

Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions

Terminated

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7